Troy R. Torgerson, MD, PhDDr. Torgerson is the co-director of the Immunology Diagnostic Laboratory. He cares for children who have immune deficiency diseases.
Dr. Torgerson participates in the clinical care of patients with immune deficiency and autoimmune disorders at Seattle Children's Hospital and coordinates care for immunodeficient patients treated by hematopoietic stem cell transplant (HSCT). His clinical interests include the diagnosis and management of children and adults with primary immunodeficiency diseases (PIDDs) and autoimmune disorders in children.
Education And Training
- Board Certified: Pediatric Rheumatology
- Medical/Professional School: Vanderbilt University School of Medicine, Nashville
- Residency: University of Washington School of Medicine, Seattle, Pediatrics
- Fellowship: University of Washington School of Medicine, Seattle, Pediatric Rheumatology
Dr. Torgerson's research interests relate to the identification of basic cellular mechanisms that jointly promote autoimmunity and immunodeficiency.
His research is focused on studies of the molecular basis of immune dysregulation present in patients with immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX). The genetic defect present in this syndrome alters the development and function of regulatory T cells, which are required for controlling immune responses.
He is a member of the Society for Pediatric Research and coordinates several joint clinical research protocols designed to optimize HSCT treatment in PIDD.